Semaglutide is the active pharmaceutical ingredient found in several popular prescription medications
In Quebec, where one in four adults is obese, the current cost of these new drugs (approximately $500 per month) would involve an annual expenditure of several hundred million dollars (in the United States the situation is even worse: the cost of a 72-week course of tirzepatide (15 mg/week) is approximately US$17,000, while the 68-week treatment with semaglutide (2.4 mg/week) is nearly US$23,000!)
Letters from your healthcare provider explaining why the medication is medically necessary for your specific situation
While the research base for microdosing, specifically, is still developing, and lower-dose protocols are being explored, though clinical evidence for efficacy at sub-therapeutic doses remains limited
The dual role of sirtuins in cancer: biological functions and implications
Glutathione, sebagai antioksidan kuat, mampu melawan radikal bebas dan melindungi sel-sel kulit dari kerusakan